Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training

The non-alcoholic fatty liver disease (NAFLD) is the most common liver pathology in developed countries with an estimated prevalence of 20 to 30% in the American population. A typically benign and asymptomatic pathology, NAFLD is characterized by hepatic steatosis and abnormal levels of hepatic enzy...

Full description

Bibliographic Details
Main Author: Jolin-Rodrigue, Gabriel
Other Authors: Chapados, Natalie
Format: Others
Language:en
Published: Université d'Ottawa / University of Ottawa 2019
Subjects:
Online Access:http://hdl.handle.net/10393/38900
http://dx.doi.org/10.20381/ruor-23150
id ndltd-uottawa.ca-oai-ruor.uottawa.ca-10393-38900
record_format oai_dc
spelling ndltd-uottawa.ca-oai-ruor.uottawa.ca-10393-389002019-03-16T05:15:27Z Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training Jolin-Rodrigue, Gabriel Chapados, Natalie Prud'homme, Denis Neonicotinoid Imidacloprid Non-alcoholic fatty liver disease NAFLD Exercise Liver Sprague-Dawley Xenobiotics The non-alcoholic fatty liver disease (NAFLD) is the most common liver pathology in developed countries with an estimated prevalence of 20 to 30% in the American population. A typically benign and asymptomatic pathology, NAFLD is characterized by hepatic steatosis and abnormal levels of hepatic enzymes stemming from an increase in circulating free fatty acids originating from white adipose tissue lipolysis, an increased de novo lipogenesis, reduced fatty acid oxidation and decreased hepatic triglycerides secretion, all within an insulin resistance context. NAFLD has the potential to progress to the non-alcoholic steatohepatitis (NASH), a condition marked by inflammation, advanced oxidative stress and fibrosis. NASH is expected to be the leading cause of liver transplant by 2020 due to its complications (i.e.: cirrhosis, hepatocellular carcinoma and liver failure). Various xenobiotics such as pesticides have been shown to promote the apparition and development of NAFLD. Of interest to this study is the neonicotinoid imidacloprid, more contemporarily known for its suspected role in the colony collapse disorder of various anthophilae species. Imidacloprid has been shown to induce hepatic oxidative stress in rats, a significant factor in the development of NAFLD and its progression to NASH. Lifestyle modifications, namely physical exercise, is a current treatment which has been proven beneficial to prevent and treat NAFLD by reducing hepatic steatosis, oxidative stress and improving insulin sensitivity. The role of any neonicotinoid on the development of NAFLD has yet to be examine and few have looked at the role of exercise in the treatment of NAFLD brought about by pesticide contamination. 2019-03-14T18:17:12Z 2019-03-14T18:17:12Z 2019-03-14 Thesis http://hdl.handle.net/10393/38900 http://dx.doi.org/10.20381/ruor-23150 en application/pdf Université d'Ottawa / University of Ottawa
collection NDLTD
language en
format Others
sources NDLTD
topic Neonicotinoid
Imidacloprid
Non-alcoholic fatty liver disease
NAFLD
Exercise
Liver
Sprague-Dawley
Xenobiotics
spellingShingle Neonicotinoid
Imidacloprid
Non-alcoholic fatty liver disease
NAFLD
Exercise
Liver
Sprague-Dawley
Xenobiotics
Jolin-Rodrigue, Gabriel
Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training
description The non-alcoholic fatty liver disease (NAFLD) is the most common liver pathology in developed countries with an estimated prevalence of 20 to 30% in the American population. A typically benign and asymptomatic pathology, NAFLD is characterized by hepatic steatosis and abnormal levels of hepatic enzymes stemming from an increase in circulating free fatty acids originating from white adipose tissue lipolysis, an increased de novo lipogenesis, reduced fatty acid oxidation and decreased hepatic triglycerides secretion, all within an insulin resistance context. NAFLD has the potential to progress to the non-alcoholic steatohepatitis (NASH), a condition marked by inflammation, advanced oxidative stress and fibrosis. NASH is expected to be the leading cause of liver transplant by 2020 due to its complications (i.e.: cirrhosis, hepatocellular carcinoma and liver failure). Various xenobiotics such as pesticides have been shown to promote the apparition and development of NAFLD. Of interest to this study is the neonicotinoid imidacloprid, more contemporarily known for its suspected role in the colony collapse disorder of various anthophilae species. Imidacloprid has been shown to induce hepatic oxidative stress in rats, a significant factor in the development of NAFLD and its progression to NASH. Lifestyle modifications, namely physical exercise, is a current treatment which has been proven beneficial to prevent and treat NAFLD by reducing hepatic steatosis, oxidative stress and improving insulin sensitivity. The role of any neonicotinoid on the development of NAFLD has yet to be examine and few have looked at the role of exercise in the treatment of NAFLD brought about by pesticide contamination.
author2 Chapados, Natalie
author_facet Chapados, Natalie
Jolin-Rodrigue, Gabriel
author Jolin-Rodrigue, Gabriel
author_sort Jolin-Rodrigue, Gabriel
title Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training
title_short Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training
title_full Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training
title_fullStr Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training
title_full_unstemmed Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training
title_sort effects of imidacloprid in the development of non-alcoholic fatty liver disease and the effects of exercise training
publisher Université d'Ottawa / University of Ottawa
publishDate 2019
url http://hdl.handle.net/10393/38900
http://dx.doi.org/10.20381/ruor-23150
work_keys_str_mv AT jolinrodriguegabriel effectsofimidaclopridinthedevelopmentofnonalcoholicfattyliverdiseaseandtheeffectsofexercisetraining
_version_ 1719004088515952640